ANGLE plc (LON:AGL – Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 2.35 and traded as high as GBX 2.90. ANGLE shares last traded at GBX 2.35, with a volume of 1,682,496 shares trading hands.
ANGLE Price Performance
The firm has a 50 day moving average price of GBX 2.35 and a two-hundred day moving average price of GBX 2.35. The company has a market cap of £7.58 million, a P/E ratio of -0.49 and a beta of 0.22. The company has a debt-to-equity ratio of 25.25, a quick ratio of 6.17 and a current ratio of 2.76.
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Further Reading
- Five stocks we like better than ANGLE
- 3 Under-the-Radar Defense Stocks With Record Backlogs
- This Korea ETF Has Soared, But the Rally May Not Be Over
- Why Guidewire’s Post-Earnings Plunge May Not Last
- Ride-Share Reckoning: Tesla Drives Into Uber’s Lane
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
